The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease.
Cailan LiQian LiJiamin XuWenzhen WuYuling WuJianhui XieXiaobo YangPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
Evidence from the meta-analysis demonstrated that CDDP combined with PCI treatment prominently reduced the incidence of MACE, improved cardiovascular functions, and inhibited inflammation in CHD patients. Therefore, CDDP combined with PCI treatment could be an effective and safe therapeutic method for CHD patients.
Keyphrases
- percutaneous coronary intervention
- end stage renal disease
- systematic review
- acute myocardial infarction
- ejection fraction
- acute coronary syndrome
- newly diagnosed
- chronic kidney disease
- st segment elevation myocardial infarction
- prognostic factors
- peritoneal dialysis
- oxidative stress
- atrial fibrillation
- coronary artery bypass grafting
- heart failure
- risk factors
- patient reported outcomes
- patient reported